The Relation of Urinary 8-OHdG, A Marker of Oxidative Stress to DNA, and Clinical Outcomes for Ischemic Stroke

Background: Oxidative stress/free radical generation after ischemic stroke contributes to neuronal cell injury. We evaluated the utility of an oxidative stress marker, urinary 8-hydroxy-2-deoxyguanosine (8-OHdG), to demonstrate an association between the changes of 8-OHdG and outcomes after acute ischemic stroke. Methods: We enrolled 44 patients (26 males and 18 females) who visited our hospital due to acute ischemic stroke. Urine was collected on admission and on Days 7, and 8-OHdG was measured by ELISA. The relationships between 8-OHdG levels, stroke subtypes, and clinical outcomes based on the NIHSS and modified Rankin Scale (mRS) upon discharge was evaluated. Results: In the overall cohort, the mean urinary level of 8-OHdG on Day 7 was increased than that on Day 0. The 8-OHdG levels on Day 0 were not different between patients with poor and good outcomes. However, an increasing rate from Day 0 to 7 (Δ 8-OHdG) in stroke patients with a poor outcome(mRS ≥3) was significantly higher than those with a good outcome (mRS ≤2) (2.54 vs 39.44, p = 0.004). Conclusions: The biochemical changes related to 8-OHdG and oxidative stress may be considered a marker of ischemic brain injury and clinical outcome of ischemic stroke.

[1]  Toru Yamashita,et al.  Dissociation and Protection of the Neurovascular Unit after Thrombolysis and Reperfusion in Ischemic Rat Brain , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Shotai Kobayashi,et al.  Edaravone (Radical Scavenger) versus Sodium Ozagrel (Antiplatelet Agent) in Acute Noncardioembolic Ischemic Stroke (EDO Trial) , 2009, Cerebrovascular Diseases.

[3]  S. Nagahiro,et al.  Edaravone, a Free Radical Scavenger, Inhibits MMP-9–Related Brain Hemorrhage in Rats Treated With Tissue Plasminogen Activator , 2009, Stroke.

[4]  K. Furie,et al.  Oxidative Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke: The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study , 2008, Stroke.

[5]  H. Itabe,et al.  Inhibition of brain damage by edaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction. , 2005, Free radical biology & medicine.

[6]  Ning Zhang,et al.  Edaravone Reduces Early Accumulation of Oxidative Products and Sequential Inflammatory Responses After Transient Focal Ischemia in Mice Brain , 2005, Stroke.

[7]  K. Katsura,et al.  Urinary 8-hydroxy-2′-deoxyguanosine and serum S100β in acute cardioembolic stroke patients , 2005, Neurological research.

[8]  S. Kuroda,et al.  Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia , 2004, Brain Research.

[9]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[10]  S. Ibayashi,et al.  Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion , 2004, Journal of the Neurological Sciences.

[11]  T. Fujita,et al.  Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. , 2004, Kidney international.

[12]  Takeshi Hayashi,et al.  Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain , 2004, Neurological research.

[13]  Á. Chamorro.  Role of Inflammation in Stroke and Atherothrombosis , 2004, Cerebrovascular Diseases.

[14]  Chuan-zhen Lu,et al.  Metabolic changes of arachidonic acid after cerebral ischemia–reperfusion in diabetic rats , 2003, Experimental Neurology.

[15]  F. Zhang,et al.  Inducible Repair of Oxidative DNA Lesions in the Rat Brain after Transient Focal Ischemia and Reperfusion , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  H. Itabe,et al.  Raised plasma oxidised LDL in acute cerebral infarction , 2003, Journal of neurology, neurosurgery, and psychiatry.

[17]  M. Evans,et al.  Progress in the analysis of urinary oxidative DNA damage. , 2002, Free radical biology & medicine.

[18]  G. D. De Meyer,et al.  Elevated Levels of Oxidative DNA Damage and DNA Repair Enzymes in Human Atherosclerotic Plaques , 2002, Circulation.

[19]  Longjian Liu,et al.  The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania , 2001, Journal of hypertension.

[20]  M. Zakhary,et al.  Oxidative stress in the context of acute cerebrovascular stroke. , 2000, Stroke.

[21]  M. Evans,et al.  Urinary 8-oxo-2′-deoxyguanosine — Source, significance and supplements , 2000, Free radical research.

[22]  G. Kojda,et al.  Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. , 1999, Cardiovascular research.

[23]  S. Love.  Oxidative Stress in Brain Ischemia , 1999, Brain pathology.

[24]  Toshiaki Watanabe,et al.  Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia , 1997, Brain Research.

[25]  G. Samsa,et al.  Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. , 1997, Stroke.

[26]  J. Musarrat,et al.  Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. , 1996, European journal of cancer.

[27]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[28]  T. Watanabe,et al.  Effect of MCI-186 on brain edema in rats. , 1989, Stroke.

[29]  P. Pasqualetti,et al.  Plasma levels of nitric oxide and stroke outcome , 2007, Journal of Neurology.

[30]  P. Chang,et al.  Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[31]  E. Otomo.  Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. , 2003, Cerebrovascular diseases.

[32]  Y. Hasui,et al.  Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA. , 2000, Research communications in molecular pathology and pharmacology.

[33]  E. Hall,et al.  Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. , 1989, Free radical biology & medicine.

[34]  R. Bloch,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.